Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
Clinical trial NCT01700569 · TERMINATED
Trial details
- NCT number
- NCT01700569
- Sponsor
- Institut Cancerologie de l'Ouest
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2019-12-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.